SPOTLIGHT -
Long-Acting Injectable Antipsychotics in the Era of COVID-19
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.